Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences has informed BSE that its Board of Directors will meet on Monday, 19 May 2025, to consider and approve the audited standalone financial results for the quarter and full year ended 31 March 2025. This is a routine regulatory disclosure under SEBI LODR Regulation 29, required ahead of any price-sensitive financial announcement. No actual numbers have been shared in this filing — only the meeting date and agenda items. The board may also discuss any other matter it considers fit, which is standard boilerplate language.
This is a procedural announcement with no immediate impact on the stock. Investors should watch for the actual audited FY25 results, which are expected to be declared on or shortly after 19 May 2025 — the numbers, not the meeting notice, will drive any price reaction.